Senior housing and mortgage reporter focused on market-moving coverage of mortgage lenders, servicing, fintech and policy, providing investors and operators timely analysis and deal flow intelligence. Kelly Richert writes on regulatory developments, loan performance trends and secondary-market dynamics, and is often cited by industry participants and asset managers for actionable reporting that informs risk assessment and capital allocation decisions.
Senior housing and mortgage reporter focused on market-moving coverage of mortgage lenders, servicing, fintech and policy, providing investors and operators timely analysis and deal flow intelligence. Kelly Richert writes on regulatory developments, loan performance trends and secondary-market dynamics, and is often cited by industry participants and asset managers for actionable reporting that informs risk assessment and capital allocation decisions.
Leverages market intelligence and regulatory insight to prioritize capital allocation toward mortgage- and senior-housing-related opportunities where information asymmetry can be exploited. Emphasizes data-driven risk assessment, credit-cycle sensitivity, and secondary-market dynamics, favoring flexible, liquid instruments and short-to-medium horizons to respond to policy shifts. Underwrites investments with operational diligence, stress-testing loan performance and servicing economics, and maintains a bias for positions that benefit from transparent, high-frequency signals.
Leverages market intelligence and regulatory insight to prioritize capital allocation toward mortgage- and senior-housing-related opportunities where information asymmetry can be exploited. Emphasizes data-driven risk assessment, credit-cycle sensitivity, and secondary-market dynamics, favoring flexible, liquid instruments and short-to-medium horizons to respond to policy shifts. Underwrites investments with operational diligence, stress-testing loan performance and servicing economics, and maintains a bias for positions that benefit from transparent, high-frequency signals.
| Trades 1615 | Longs Won 895/1615 55% | Profit Factor 18.47 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $261,561.65 |
| Average Win $76,948.7 | Best Trade (Oct 06) $6.35M | Sharpe Ratio -18.32 |
| Average Loss -$5,178.38 | Worst Trade (Oct 01) -$225,386.71 | Z-Score -0.98 (67.47%) |
| Commissions $0 | Avg. Trade Length 8m 1w 4d | Expectancy $40,334.77 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 35,714 | 32,143 | 28,571 | 25,000 | 21,429 | 17,857 | 14,286 | 10,714 | 7,143 | 3,571 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 4,380 | $1.19M | $1.45M | - | $260,953.83 | 21.91% | -0.434% |
ABBV AbbVie Inc. | 5,762 | $1.33M | $1.53M | - | $200,403.85 | 15.05% | +0.053% |
ABT Abbott Laboratories | 6,133 | $820,728.39 | $613,545.32 | - | -$207,183.07 | -25.24% | -0.06% |
AMP Ameriprise Financial, Inc. | 732 | $359,588.64 | $362,918.28 | - | $3,329.64 | 0.93% | +0.172% |
AVGO Broadcom Inc. | 645 | $216,056.99 | $239,959.35 | - | $23,902.36 | 11.06% | +2.626% |
AXP American Express Company | 3,683 | $1.23M | $1.13M | - | -$107,518.44 | -8.71% | +0.599% |
BA Boeing Company | 5,372 | $957,182.97 | $1.03M | - | $68,063.23 | 7.11% | -0.97% |
BMY Bristol-Myers Squibb Company | 4,996 | $229,271.5 | $296,287.78 | - | $67,016.28 | 29.23% | +0.842% |
BRK-A Berkshire Hathaway Inc. | 2 | $1.27M | $1.52M | - | $251,120 | 19.79% | +0.479% |
BRK-B Berkshire Hathaway Inc. | 3,574 | $1.8M | $1.82M | - | $18,767.08 | 1.04% | +0.736% |
CAT Caterpillar Inc. | 206 | $118,011.3 | $180,491.02 | - | $62,479.72 | 52.94% | +3.305% |
CSCO Cisco Systems, Inc. | 1,900 | $142,371.12 | $217,417 | - | $75,045.88 | 52.71% | +1.427% |
CSRE Cohen & Steers Real Estate Active ETF | 27,488 | $704,238.64 | $738,190.24 | - | $33,951.6 | 4.82% | +0.921% |
CVS CVS Health Corporation | 4,280 | $323,547.36 | $369,834.8 | - | $46,287.44 | 14.31% | -0.69% |
DEM WisdomTree Emerging Markets High Dividend Fund | 3,793 | $174,649.07 | $211,839.05 | - | $37,189.98 | 21.29% | +0.036% |
DFAT Dimensional US Targeted Value ETF | 7,939 | $432,113.08 | $540,725.29 | - | $108,612.21 | 25.14% | +0.176% |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 10,035 | $245,055.02 | $377,013.95 | - | $131,958.93 | 53.85% | +0.32% |
DFIV Dimensional International Value ETF | 7,428 | $272,973.48 | $415,262.34 | - | $142,288.86 | 52.13% | +0.332% |
DSTL Distillate U.S. Fundamental Stability & Value ETF | 4,541 | $249,558 | $294,347.62 | - | $44,789.62 | 17.95% | +0.201% |
EFG iShares MSCI EAFE Growth ETF | 18,122 | $2.01M | $2.2M | - | $192,761.3 | 9.59% | +0.479% |